Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 35, Issue 3, 1997, Pages 191-198

  Will Wodzig, K ^a   Kragten, Johannes A ^b   Hermens, Wim Th ^c   Glatz, Jan F C ^c   Van Dieijen Visser, Marja P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATININE; FATTY ACID BINDING PROTEIN; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYBUTYRATE DEHYDROGENASE; MYOGLOBIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CARRIER PROTEINS; CREATINE KINASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYDROXYBUTYRATE DEHYDROGENASE; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYELIN P2 PROTEIN; MYOCARDIAL INFARCTION; MYOGLOBIN; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030892361     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hearse D. Molecular enzyme release. J Mol Med 1977; 2:185-200.
2. Kagen L. Myoglobin: methods and diagnostic uses. CRC Crit Rev Lab Sci 1978; 9:273-302.
3. Cairns J, Missirlis E, Walker W. Usefulness of serial determinations of myoglobin and creatinine kinase in serum compared for assessment of acute myocardial infarction. Clin Chem 1983; 29:469-73.
4. Delanghe J, DeBuyzere M, Cluyse L, Thierens H, Clement D. Acute myocardial infarction size and myoglobin release into serum. Eur J Clin Chem Clin Biochem 1992; 30:823-30.
5. Mair J, Artner-Dworzak E, Lechleiter P, Morass B, Smidt J, Wagner I, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68:462-8.
6. Ellis K, Little T, Masud Z, Liberman H, Morris D, IClocke F. Early non-invasive detection of successful reperfusion in patients with acute myocardial infarction. 1. 1988; 78:1352-7.
7. Katus HA, Diederich K, Scheffold T, Uellner M, Schwarz F, Kubler W. Non-invasive assessment of infarct reperfusion: the predictive power of time to peak value of myoglobin, CKMB and CK in serum. Eur Heart J 1988; 619-24.
8. Yamashita T, Abe S, Arima S, Nomoto K, Miyata M, Maruyama I, et al. Myocardial infarct size can be estimated from serial plasma myoglobin measurements within 4 hours of reperfusion. Circulation 1993; 87:1840-9.
9. Tanaka T, Hirota Y, Sohmiya K., Nishimura S, Kawamura K. Serum and urinary heart fatty acid binding protein in acute myocardial infarction. Clin Biochem 1991; 24:195-201.
10. Kleine A, Glatz J, Van Nieuwenhoven F, Van der Vusse G. Release of fatty-acid binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116:155-62.
11. Glatz J, Kleine A, Van Nieuwenhoven F, Hermens WT, Van Dieijen-Visser M, Van der Vusse G. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994; 71:135-40.
12. Glatz J, Van der Vusse G. Cellular fatty acid binding proteins: current concepts and future directions. Mol Cell Biochem 1990; 98:237-51.
13. Glatz J, Van der Vusse G. Cellular fatty acid-binding proteins: their function and physiological significance. Progress in Lipid Research 1996. In press.
14. Van Nieuwenhoven F, Kleine A, Wodzig K, Hermens W, Kragten H, Maessen J, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92:2848-54.
15. Yoshimoto K, Tanaka T, Somiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acidbinding protein as an indicator of acute myocardial infarction. Heart Vessels 1995; 10:304-9.
16. Kragten J, Van Nieuwenhoven F, Van Dieijen-Visser M, Theunissen P, Hermens W, Glatz J. Distribution of myoglobin and fatty acid binding protein in human cardiac autopsies. Clin Chem 1996; 42:337-8.
17. Hallgren R, Karlsson F, Roxin L, Venge P. Myoglobin turnover, influence of renal and extrarenal factors. J Lab Clin Med 1978; 91:246-54.
18. Gorski J, Hermens W, Borawski J, Mysliwiec M, Glatz J. Fatty acid-binding protein concentration of patients with chronic renal failure is elevated. Clin Chem 1996. In press.
19. Delanghe J, Chapelle J, Magdeleine E, DeBuyzere M. Quantitative turbidimetric assay for determining myoglobin evaluated. Ann Clin Biochem 1991; 28:474-9.
20. Wodzig K, Pelsers M, Van der Vusse G, Roos W, Glatz J. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein, Ann Clin Biochem 1996. In press.
21. Visser M, Krill M, Willems G, Hermens W. Selection of a suitable model for the plasma clearance and distribution of cardiac enzymes in the dog. Cardiovasc Res 1981; 15:35-42.
22. Van Kreel B, Van der Veen, Willems G, Hermens W. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; (Heart Circ Vol 33): H747-54.
23. Willems G, Visser M, Krill M, Hermens W. Quantitative analysis of plasma enzyme levels based on simultaneous determination of different enzymes. Cardiovasc Res 1982; 16: 120-31.
24. Koskelo P, Kekki M, Wager O. Kinetic behavior of 1311-1a-beled myoglobin in human beings. Clin Chim Acta 1967; 17:339-47.
25. Sylven C. The kinetics of myoglobin in old volunteers and in patients with acute myocardial infarction. Scand J Clin Lab Invest 1989; 38:561-5.
26. Groth T, Sylven C. Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase - as studied by the single injection method. Scand J Clin Lab Invest 1981; 44:65-78.
27. Geigy. Wissenschaftliche Tabellen, Körperflüssigkeiten 8. Basel, 1977.
28. Renkin E. Multiple pathways of capillary permeability. Circ Res 1977; 41:435-43.
29. Renkin E, Curry F. Transport of water and solutes across capillary endothelium. In: Giebisch G, Tosteson DC, Ussing HH, editors. Membrane transport in biology. Berlin: Springer Verlag 1979:1-45.
30. Groth T, Hakman M, Sylven C. Size estimation of acute myocardial infarction from serial serum myoglobin observations with due consideration of individual differences in basic kinetics. Scan J Clin Lab Invest 1984; 44:65-78.
31. Grottum P, Sederholm M, Kjekshus J. Quantitative and temporal relation between the release of myoglobin and creatine kinase and the evolution of vectorcardiographic changes during acute myocardial infarction in man. Cardiovasc Res 1987; 21:652-9.
32. Rabkin R, Dahl D. Renal uptake and disposal of proteins and peptides. New York: Plenum Press, 1993.
33. Fsuji R, Tanaka T, Sohmiya K, Nishimura S, Kawamura K. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Int J Cardiol 1993; 41:209-17.
34. Abildgaard U, Andersen J, Daugaard G, Aldershville J, Nielsen S, Christensen N, et al. Renal function in patients with untreated acute myocardial infarction. Scand J Clin Lab Invest 1992; 52:689-5.
35. Efendigil M, Harley A, Deegan T, McKendrick C. Changes in glomerular filtration rate following myocardial infarction. Cardiovascular Research 1975; 9:741-4.
36. Kagen L, Scheldt S, Butt A. Serum myoglobin in myocardial infarction. The "staccato phenomenon". Am J Med 1977; 62:86-92.
37. Ellis A, Saran B. Kinetics of myoglobin release and prediction of myocardial depletion after coronary artery reperfusion. Circulation 1989; 80:676-83.
38. Hermens W, Van der Veen F, Willems G, Mullers-Bouman M, Schrijvers-van Schendel A, Reneman R. Complete recovery in plasma of enzymes lost from the heart after permanent coronary occlusion in the dog. Circulation 1990; 81:649-59.